Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has
increased over the last few decades. It derives from follicular thyroid cells. Generally …

Thyroid carcinoma is rare among human malignancies (! 1%) but is the most frequent
endocrine cancer, accounting for about 5% of thyroid nodules (1). The latter are very …

Background: Publication of the 2015 American Thyroid Association (ATA) management
guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …

Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective
as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid …

Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration …

THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …

Thyroid cancer is rapidly increasing in incidence, but the mortality rate remains flat. Debate
has arisen over the need to detect or treat most thyroid cancers early, given their favorable …

Thyroid cancer comprises a broad spectrum of diseases with variable prognoses. Although
most patients with this disease have excellent overall survival, there are some who do not …